Time Warner (TWX) Shareholder Dynamic Capital Management LTD Has Decreased Its Position as Market Value Rose; Acadia Pharmaceuticals Com (ACAD) Holder Gilder Gagnon Howe & Co Cut Its Holding

April 24, 2018 - By Winifred Garcia

Time Warner Inc. (NYSE:TWX) Logo

Gilder Gagnon Howe & Co Llc decreased its stake in Acadia Pharmaceuticals Inc Com (ACAD) by 8.56% based on its latest 2017Q4 regulatory filing with the SEC. Gilder Gagnon Howe & Co Llc sold 10,545 shares as the company’s stock declined 22.49% with the market. The institutional investor held 112,626 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $3.39 million, down from 123,171 at the end of the previous reported quarter. Gilder Gagnon Howe & Co Llc who had been investing in Acadia Pharmaceuticals Inc Com for a number of months, seems to be less bullish one the $2.43 billion market cap company. The stock decreased 2.21% or $0.44 during the last trading session, reaching $19.48. About 914,064 shares traded. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 36.38% since April 24, 2017 and is downtrending. It has underperformed by 47.93% the S&P500.

Dynamic Capital Management Ltd decreased its stake in Time Warner Inc (TWX) by 61.18% based on its latest 2017Q4 regulatory filing with the SEC. Dynamic Capital Management Ltd sold 13,396 shares as the company’s stock rose 1.97% while stock markets declined. The hedge fund held 8,500 shares of the television services company at the end of 2017Q4, valued at $777,000, down from 21,896 at the end of the previous reported quarter. Dynamic Capital Management Ltd who had been investing in Time Warner Inc for a number of months, seems to be less bullish one the $74.39B market cap company. The stock decreased 1.01% or $0.97 during the last trading session, reaching $95.39. About 2.21 million shares traded. Time Warner Inc. (NYSE:TWX) has declined 3.25% since April 24, 2017 and is downtrending. It has underperformed by 14.80% the S&P500.

Among 41 analysts covering Time Warner Inc. (NYSE:TWX), 18 have Buy rating, 0 Sell and 23 Hold. Therefore 44% are positive. Time Warner Inc. had 125 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was downgraded by Bernstein to “Market Perform” on Thursday, August 20. The stock of Time Warner Inc. (NYSE:TWX) earned “Hold” rating by RBC Capital Markets on Friday, September 15. The firm has “” rating given on Thursday, January 21 by Albert Fried. The firm has “Hold” rating given on Thursday, July 13 by RBC Capital Markets. The stock has “Mkt Perform” rating by FBR Capital on Friday, February 19. KeyBanc Capital Markets maintained Time Warner Inc. (NYSE:TWX) on Monday, November 20 with “Hold” rating. The stock of Time Warner Inc. (NYSE:TWX) has “Market Perform” rating given on Tuesday, July 26 by FBR Capital. Topeka Capital Markets maintained Time Warner Inc. (NYSE:TWX) rating on Tuesday, September 15. Topeka Capital Markets has “Buy” rating and $107 target. The company was downgraded on Thursday, November 5 by Credit Agricole. Pivotal Research upgraded the shares of TWX in report on Wednesday, November 2 to “Buy” rating.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.15, from 0.76 in 2017Q3. It increased, as 64 investors sold TWX shares while 363 reduced holdings. 122 funds opened positions while 265 raised stakes. 598.25 million shares or 1.97% more from 586.69 million shares in 2017Q3 were reported. Yakira Mngmt owns 291,146 shares or 8.61% of their US portfolio. Longfellow Mgmt Co Limited Com holds 120,000 shares. Stephens Ar owns 7,315 shares. Jet Cap Invsts Lp holds 7.22% or 1.70M shares in its portfolio. Zeke Cap Lc reported 0.08% of its portfolio in Time Warner Inc. (NYSE:TWX). Amf Pensionsforsakring Ab invested in 0.73% or 810,295 shares. Plante Moran Finance Ltd Llc owns 970 shares. Community National Bank Na holds 0% of its portfolio in Time Warner Inc. (NYSE:TWX) for 138 shares. Advisory Services Network Ltd Liability Company stated it has 782 shares. 1.31M are held by Comml Bank Of Montreal Can. Trust Department Mb National Bank N A reported 556 shares. Wafra Advisory New York holds 56,445 shares or 0.24% of its portfolio. Meyer Handelman holds 0.32% or 72,328 shares in its portfolio. Perigon Wealth Mngmt Ltd Liability reported 1,220 shares. Drw Secs Limited Com, a Illinois-based fund reported 10,920 shares.

Since December 14, 2017, it had 0 insider buys, and 3 insider sales for $2.88 million activity. 4,019 shares were sold by BARR WILLIAM P, worth $390,647. OLAFSSON OLAF sold 23,450 shares worth $2.11M.

Dynamic Capital Management Ltd, which manages about $932.59M and $290.80 million US Long portfolio, upped its stake in Alexion Pharmaceuticals Inc (NASDAQ:ALXN) by 4,612 shares to 7,539 shares, valued at $902,000 in 2017Q4, according to the filing. It also increased its holding in Ddr Corp (NYSE:DDR) by 169,549 shares in the quarter, for a total of 185,405 shares, and has risen its stake in Microsoft Corp (NASDAQ:MSFT).

Analysts await Time Warner Inc. (NYSE:TWX) to report earnings on April, 26 before the open. They expect $1.76 EPS, up 6.02% or $0.10 from last year’s $1.66 per share. TWX’s profit will be $1.37B for 13.55 P/E if the $1.76 EPS becomes a reality. After $1.60 actual EPS reported by Time Warner Inc. for the previous quarter, Wall Street now forecasts 10.00% EPS growth.

Since January 2, 2018, it had 1 insider buy, and 3 selling transactions for $3.94 million activity. Baity Glenn sold $2.24 million worth of stock. Brege Laura had sold 25,000 shares worth $751,543.

Analysts await ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to report earnings on May, 8. They expect $-0.56 EPS, up 22.22% or $0.16 from last year’s $-0.72 per share. After $-0.55 actual EPS reported by ACADIA Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 1.82% negative EPS growth.

Among 12 analysts covering ACADIA Pharmaceuticals (NASDAQ:ACAD), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. ACADIA Pharmaceuticals had 35 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has “Buy” rating given on Wednesday, October 4 by Cowen & Co. Piper Jaffray upgraded it to “Neutral” rating and $48.0 target in Thursday, August 27 report. The firm has “Outperform” rating by Cowen & Co given on Sunday, August 9. H.C. Wainwright maintained it with “Buy” rating and $60.0 target in Wednesday, November 8 report. Cowen & Co maintained ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) rating on Tuesday, April 10. Cowen & Co has “Buy” rating and $5000 target. The company was reinitiated on Wednesday, October 19 by Roth Capital. The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has “Buy” rating given on Monday, June 26 by Jefferies. J.P. Morgan maintained it with “Buy” rating and $50.0 target in Thursday, October 5 report. The firm has “Market Perform” rating given on Tuesday, May 3 by Leerink Swann. The firm has “Buy” rating by Needham given on Friday, August 7.

Investors sentiment increased to 1.26 in 2017 Q4. Its up 0.25, from 1.01 in 2017Q3. It is positive, as 30 investors sold ACAD shares while 47 reduced holdings. 32 funds opened positions while 65 raised stakes. 117.35 million shares or 3.35% more from 113.55 million shares in 2017Q3 were reported. Goldman Sachs Grp Inc Inc Inc, a New York-based fund reported 1.19M shares. Principal Inc owns 32,853 shares or 0% of their US portfolio. Citigroup Inc owns 0% invested in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 73,031 shares. The Arizona-based Tci Wealth has invested 0.02% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Macquarie Ltd holds 7,200 shares or 0% of its portfolio. 1.52 million were accumulated by First Advsr L P. Tocqueville Asset Limited Partnership has 31,160 shares for 0.01% of their portfolio. Franklin Resource invested in 3.24 million shares. Profund Advisors invested in 35,978 shares. Garrison Bradford And Associate Inc, New York-based fund reported 74,150 shares. Creative Planning, Kansas-based fund reported 72,314 shares. The Florida-based Raymond James Fin Services Advsrs has invested 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Orbimed Advsrs Limited Liability Co reported 849,100 shares or 0.32% of all its holdings. Dekabank Deutsche Girozentrale accumulated 0.02% or 68,900 shares. Capital Ww Investors holds 0.02% or 2.83 million shares in its portfolio.

Gilder Gagnon Howe & Co Llc, which manages about $6.26 billion and $7.44B US Long portfolio, upped its stake in Scientific Games Crp Cl A (NASDAQ:SGMS) by 8,012 shares to 72,977 shares, valued at $3.74 million in 2017Q4, according to the filing. It also increased its holding in Adr by 360,801 shares in the quarter, for a total of 917,123 shares, and has risen its stake in Abiomed Inc (NASDAQ:ABMD).

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Winifred Garcia

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: